CD8A and melanoma: As 4-1BB co-stimulation preferentially expands CD8+ T cells (44), our data were consistent with reports that 4-1BB plus PD-1, rather than LAG-3 plus PD-1, exhibited synergy in B16F10 melanoma (45).